A retrospective study of percutaneous cholecystostomy outcomes in a community hospital

Authors

  • Jonathan Meija Department of Surgery, Flushing Hospital Medical Center, Flushing, New York, USA
  • Melissa Meghpara Department of Surgery, Flushing Hospital Medical Center, Flushing, New York, USA
  • Omar Wain Department of Surgery, Flushing Hospital Medical Center, Flushing, New York, USA
  • Tyler Liguori New York Institute of Technology, New York, USA
  • Sutasinee Nithisoontorn Flushing Hospital Medical Center, Flushing, New York, USA
  • Robert Solomon Department of Surgery, Flushing Hospital Medical Center, Flushing, New York, USA
  • Martine A. Louis Department of Surgery, Flushing Hospital Medical Center, Flushing, New York, USA
  • Nageswara Mandava Department of Surgery, Flushing Hospital Medical Center, Flushing, New York, USA

DOI:

https://doi.org/10.18203/2349-2902.isj20240163

Keywords:

AC, PCT, Post-operative outcomes, Community hospital, Critically ill patients

Abstract

Background: The gold standard of treatment for acute cholecystitis (AC) typically involves operative intervention, specifically cholecystectomy. However, initial nonoperative management rather than immediate cholecystectomy has been recommended for critically ill patients. Non-operative interventions, such as percutaneous cholecystostomy (PCT), may represent viable alternatives. The current study examines risk factors associated with worse outcomes of AC among critically ill patients with AC treated conservatively.  

Methods: This retrospective study examined data from 121 patients with AC presenting to a NYC-area community hospital. Differences in demographic, clinical, and procedural characteristics were examined in relation to post-operative outcomes, including mortality.

Results: The sample tended to be older, with 31% of patients identifying as non-Hispanic white. One-third of the sample were admitted to the ICU. The median time between admission placement and PCT was 2 days, the median time PCT was left in place was 42 days. The overall 90-day mortality rate was 21% and 33% among ICU patients. Patients identifying as non-Hispanic white and those with more severe clinical presentation were at higher risk for mortality within 90 days. Admission to intensive care units (ICU) was significantly associated with 90-day mortality.

Conclusions: The results of the current study provide a snapshot into the profiles of patients at-risk for negative outcomes following PCT placement. Sociodemographic risk factors and clinical severity were associated with increased risk of mortality among patients seen at a diverse, community hospital. These findings support the use of risk-stratified decision making regarding non-operative treatments of AC.

References

Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6(2):172.

Indar AA, Beckingham IJ. Acute cholecystitis. BMJ. 2002;325(7365):639-43.

Baron T, Grimm I, Swanstrom L. Interventional Approaches to Gallbladder Disease. N Eng J Med. 2015;373(4):357-65.

Ambe P, Kaptanis S, Papadakis M, Weber S, Jansen S, Zirngibl H. The Treatment of Critically Ill Patients with Acute Cholecystitis. Dtsch Arztebl Int. 2016;113(33-34):545-51.

Winbladh A, Gullstrand P, Svanvik J, Sandström P. Systematic review of cholecystostomy as a treatment option in acute cholecystitis. HPB. 2009;11(3):183-93.

Mayo Clinic. Cholecystectomy (gallbladder removal). Available at: https://www.mayoclinic.org/tests-procedures/cholecystectomy/about/pac-20384818#:~:text=Bleeding,as%20blood%20clots%20and%20pneumonia. Accessed on 12 September, 2023.

Cherng N, Witkowski E, Sneider E, Wiseman J, Lewis J, Litwin D et al. Use of Cholecystostomy Tubes in the Management of Patients with Primary Diagnosis of Acute Cholecystitis. J Am College Surgeons. 2012;214(2):196-201.

Hadi YB, Muhammad W, Umer HM, Alam A, Alvi A, Khan MR et al. Bacterobilia in acute cholecystitis: bile cultures' isolates. J Pak Med Asso. 2016;66(10):S50-52.

Suri A, Yasir M, Kapoor M, Aiman A, Kumar A. Prospective Study on Biliary Bacteriology In Calcular Disease Of The Gall Bladder And The Role Of Common Newer Antibiotics. Internet J Surg. 2009;22(2):1-5.

Macchini D, Degrate L, Oldani M, Leni D, Padalino P, Romano F, Gianotti L. Timing of percutaneous cholecystostomy tube removal: systematic review. Edizioni Minerva Medica. 2016;71(6):415-24.

Blanco P, Do Pico J. Ultrasound-guided percutaneous cholecystostomy in acute cholecystitis: case vignette and review of the technique. J Ultrasound. 2015;18(4);311-5.

Altieri MS, Bevilacqua L, Yang J, Toby ME, Jason BY, Marta LM et al. Cholecystectomy following percutaneous cholecystostomy tube placement leads to higher rate of CBD injuries. Surg Endosc. 2019;33(8):2686-90.

Alvino DML, Fong ZV, McCarthy CJ, George V, Keith DL, Peter RM et al. Long-Term Outcomes Following Percutaneous Cholecystostomy Tube Placement for Treatment of Acute Calculous Cholecystitis. J Gastrointest Surg. 2017;21(5):761-9.

Schlottmann F, Gaber C, Strassle PD, Patti MG, Charles AG. Cholecystectomy Vs. Cholecystostomy for the Management of Acute Cholecystitis in Elderly Patients. J Gastrointest Surg. 2019;23(3):503-9.

Colonna AL, Griffiths TM, Robison DC, Toby ME, Jason BY, Marta LM et al. Cholecystostomy: Are we using it correctly? Am J Surg. 2019;217(6):1010-15.

Saddetin Er, Berkem H, Özden S, Birkan B, Erdinç Ç, Mesut T et al. Clinical course of percutaneous cholecystostomies: A cross-sectional study. World J Clin Cases. 2020;8(6):1033-41.

Downloads

Published

2024-01-30

Issue

Section

Original Research Articles